Market Research Reports and Industry Reports

Healthcare Analytical Testing Services Market by Type (Stability, Raw Materials, Method Validation, Microbial, Environmental Monitoring, Bioanalytical Services), by End User (Pharmaceutical Companies, Medical Device Companies) - Global Forecast to 2021

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

The global healthcare analytical testing services market is estimated to grow at a CAGR of 11.3% from 2016 to 2021, to reach USD 4.13 billion by 2021 from USD 2.42 billion in 2016. Growth in this market is mainly attributed to the growing demand for analytical services for biologics and large-molecule drugs, increasing outsourcing of analytical testing by pharmaceutical companies, rising demand from the nutraceutical industry, and increasing acceptance of the QbD (Quality by Design) approach in pharmaceutical research/manufacturing. In addition, the high quality standards in the pharmaceutical industry, rapid growth in the biosimilars and biologics market, and presence of a large pool of analytical testing providers are further expected to drive the growth of this market. However, the pricing pressure faced by market players and shortage of skilled professionals in the healthcare analytical testing services industry may hinder the growth of this market to a certain extent during the forecast period.

In this report, the healthcare analytical testing services market is segmented on the basis of services, samples, end users, and regions. In 2015, the bioanalytical testing segment accounted for the largest share of the global healthcare analytical testing services market, by type. The large share of this segment can primarily be attributed to the large number of biologic molecules in the pipeline and the growing biopharmaceutical industry. On the basis of samples, the raw materials segment accounted for the largest share of the global healthcare analytical testing services market. In 2015, the pharmaceutical and biopharmaceutical companies segment accounted for the largest share of the global healthcare analytical testing services market, by end user. This large share for pharmaceutical and biopharmaceutical companies is due to the increased R&D expenditure to develop new drug molecules, growing focus on delivering high-quality products, and rising demand for analytical testing by regulators.

Geographically, North America commanded a major share of the healthcare analytical testing services market in 2015. However, Asia-Pacific is expected to witness the highest growth rate during the forecast period. Growth in the Asia-Pacific market can be attributed to the large pool of pharmaceutical and biopharmaceutical companies, government support from both an economic and policy standpoint to drive innovation in life sciences, and rapidly increasing demand for outsourcing of analytical testing.

Some of the prominent players in the healthcare analytical testing services market include Exova Group Plc. (U.K.), Eurofins Scientific SE (Luxembourg), SGS (Switzerland), PPD Inc. (U.S.), WuXi PharmaTech (Cayman) Inc. (China), Charles River Laboratories International Inc. (U.S.), Source BioScience Plc. (U.K.), Anabiotec (Belgium), Intertek Group Plc. (U.K.), Medistri SA (Switzerland), Pace Analytical Services Inc. (U.S.), and BioReliance Corporation (U.S.).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms in garnering greater market shares. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the service portfolios offered by the top players in the healthcare analytical testing services market. The report analyzes the healthcare analytical testing services market by service type, sample type, end user, and region
Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new services launches in the healthcare analytical testing services market
Market Development: Comprehensive information about the lucrative emerging markets by product and region
Market Diversification: Exhaustive information about new services, growing geographies, recent developments, and investments in the healthcare analytical testing services market
Competitive Assessment: In-depth assessment of market shares, growth strategies, and services, and testing capabilities of leading players in the healthcare analytical testing services market

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.1.1 SECONDARY SOURCES
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.3 KEY INDUSTRY INSIGHTS
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
2.4 MARKET SHARE ESTIMATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET OVERVIEW
4.2 ASIA-PACIFIC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER
4.3 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC SNAPSHOT
4.4 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: GEOGRAPHIC MIX
4.5 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DEVELOPING VS. DEVELOPED COUNTRIES
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET SEGMENTATION
5.2.1 BY TYPE
5.2.2 BY END USER
5.2.3 BY SAMPLE
5.3 MARKET DYNAMICS
5.4 KEY MARKET DRIVERS
5.4.1 GROWING DEMAND FOR ANALYTICAL SERVICES FOR BIOLOGICS AND LARGE-MOLECULE DRUGS
5.4.2 INCREASING OUTSOURCING OF ANALYTICAL TESTING BY PHARMACEUTICAL COMPANIES
5.4.3 RISING DEMAND FROM THE NUTRACEUTICAL INDUSTRY
5.4.4 INCREASING ACCEPTANCE OF THE QBD APPROACH IN PHARMA RESEARCH/MANUFACTURING
5.5 KEY MARKET RESTRAINTS
5.5.1 PRICING PRESSURE FACED BY MAJOR PLAYERS
5.5.2 SHORTAGE OF SKILLED PROFESSIONALS
5.6 KEY MARKET OPPORTUNITY
5.6.1 RISING DEMAND FOR SPECIALIZED ANALYTICAL TESTING SERVICES
5.7 KEY CHALLENGES
5.7.1 INNOVATIVE FORMULATIONS AND MEDICAL DEVICES DEMANDING A UNIQUE ANALYTICAL TESTING APPROACH
5.7.2 DEVELOPMENT OF APPROPRIATE DISSOLUTION METHODS
5.7.3 NEED TO IMPROVE THE SENSITIVITY OF ANALYTICAL METHODS TO DETECT DEGRADATION PRODUCTS AND ABILITY TO SEPARATE KNOWN IMPURITIES
6 INDUSTRY INSIGHTS
6.1 INDUSTRY TRENDS
6.1.1 GROWING CONSOLIDATION IN THE HEALTHCARE ANALYTICAL TESTING SERVICES INDUSTRY
6.1.2 OUTSOURCING OF ANALYTICAL SERVICES AND PREFERRED-VENDOR PARTNERSHIPS
6.1.2.1 Preferred-vendor Partnerships
6.2 REGULATORY ANALYSIS
7 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY TYPE
7.1 INTRODUCTION
7.2 BIOANALYTICAL TESTING SERVICES
7.2.1 CELL-BASED ASSAYS
7.2.2 VIROLOGY TESTING
7.2.2.1 In Vitro Assays
7.2.2.2 In Vivo Assays
7.2.2.3 Species-specific Viral PCR Assays
7.2.3 METHOD DEVELOPMENT OPTIMIZATION AND VALIDATION
7.2.4 IMMUNOGENICITY AND NEUTRALIZING ANTIBODY TESTING
7.2.5 BIOMARKER TESTING
7.2.6 PHARMACOKINETIC TESTING
7.2.7 METABOLITE PROFILING AND MASS BALANCE STUDIES
7.3 PHYSICAL CHARACTERIZATION SERVICES
7.3.1 LASER PARTICLE SIZE ANALYSIS
7.3.2 THERMAL ANALYSIS
7.3.3 IMAGE ANALYSIS
7.3.4 SURFACE AREA ANALYSIS
7.3.5 OTHER PHYSICAL CHARACTERIZATION SERVICES
7.4 METHOD VALIDATION
7.4.1 EXTRACTABLES & LEACHABLES METHOD DEVELOPMENT AND VALIDATION
7.4.2 PROCESS IMPURITY METHOD DEVELOPMENT AND VALIDATION
7.4.3 CLEANING VALIDATION METHOD DEVELOPMENT
7.4.4 ANALYTICAL STANDARD CHARACTERIZATION
7.4.5 PEAK IDENTIFICATION
7.4.6 TECHNICAL CONSULTING
7.4.7 OTHER METHOD VALIDATION SERVICES
7.5 RAW MATERIAL TESTING
7.5.1 COMPLETE COMPENDIAL TESTING
7.5.2 HEAVY METAL TESTING
7.5.3 CONTAINER TESTING
7.5.4 KARL FISCHER ANALYSIS
7.5.5 WET CHEMISTRY ANALYSIS
7.5.6 OTHER RAW MATERIAL TESTING SERVICES
7.6 BATCH RELEASE TESTING SERVICES
7.6.1 DISSOLUTION TESTING
7.6.2 PHYSICAL TESTS
7.6.3 ELEMENTAL IMPURITY TESTING
7.6.4 DISINTEGRATION TESTING
7.6.5 HARDNESS TESTING
7.6.6 FRIABILITY TESTING
7.6.7 OTHER BATCH RELEASE TESTING SERVICES
7.7 STABILITY TESTING
7.7.1 DRUG SUBSTANCE STABILITY TESTING
7.7.2 FORMULATION EVALUATION STABILITY TESTING
7.7.3 STABILITY INDICATING METHOD VALIDATION
7.7.4 ACCELERATED STABILITY TESTING
7.7.5 PHOTOSTABILITY TESTING
7.7.6 COMPARATIVE STABILITY TESTING
7.7.7 OTHER STABILITY TESTING SERVICES
7.8 MICROBIAL TESTING
7.8.1 MICROBIAL LIMIT TESTING
7.8.2 STERILITY TESTING
7.8.3 ENDOTOXIN TESTING
7.8.4 PRESERVATIVE EFFICACY TESTING
7.8.5 WATER TESTING
7.8.6 OTHER MICROBIAL TESTING SERVICES
7.9 ENVIRONMENTAL MONITORING
7.9.1 AIR TESTING
7.9.2 WASTEWATER/ETP TESTING
7.9.3 OTHER ENVIRONMENTAL MONITORING SERVICES
8 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY SAMPLE
8.1 INTRODUCTION
8.2 RAW MATERIALS
8.3 FINISHED PRODUCTS
8.4 IN-PROCESS SAMPLES
8.5 ENVIRONMENTAL SAMPLES
9 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY END USER
9.1 INTRODUCTION
9.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
9.3 MEDICAL DEVICE COMPANIES
9.4 CONTRACT RESEARCH ORGANIZATIONS
10 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY REGION
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.3 EUROPE
10.3.1 GERMANY
10.3.2 U.K.
10.3.3 FRANCE
10.3.4 ITALY
10.3.5 SPAIN
10.3.6 REST OF EUROPE
10.4 ASIA-PACIFIC (APAC)
10.4.1 CHINA
10.4.2 JAPAN
10.4.3 INDIA
10.4.4 REST OF APAC
10.5 REST OF THE WORLD (ROW)
10.5.1 LATIN AMERICA
10.5.2 MIDDLE EAST AND AFRICA
11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.2 MARKET SHARE ANALYSIS
11.3 COMPETITIVE SITUATION AND TRENDS
11.3.1 ACQUISITIONS
11.3.2 EXPANSIONS
11.3.3 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS
11.3.4 SERVICE LAUNCHES
12 COMPANY PROFILES
(Business Overview, Products & Services, Developments, MnM View)*
12.1 INTRODUCTION
12.2 EUROFINS SCIENTIFIC SE
12.3 SGS
12.4 CHARLES RIVER LABORATORIES INTERNATIONAL INC.
12.5 WUXI PHARMATECH (CAYMAN) INC.
12.6 PPD INC.
12.7 EXOVA GROUP PLC
12.8 PACE ANALYTICAL SERVICES INC.
12.9 INTERTEK GROUP PLC.
12.1 BIORELIANCE CORPORATION (MERCK KGAA)
12.11 SOURCE BIOSCIENCE
12.12 ENVIGO
12.13 ANABIOTEC
12.14 MEDISTRI SA
*Details on MarketsandMarkets view, Introduction, Product & Services, New Developments might not be captured in case of unlisted companies.
13 APPENDIX
13.1 INSIGHTS OF INDUSTRY EXPERTS
13.2 OTHER DEVELOPMENTS
13.3 DISCUSSION GUIDE
13.4 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.5 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
13.6 RELATED REPORTS


List Of Tables

 TABLE 1 BUSINESS EXPENDITURE ON R&D (BERD) IN THE PHARMACEUTICAL INDUSTRY AS A PROPORTION OF GDP AND TOTAL BERD (2011)
 TABLE 2 ACTIVITIES OUTSOURCED IN THE PHARMACEUTICAL INDUSTRY (2014 VS. 2015)
 TABLE 3 REGULATORY DOCUMENTS INTRODUCING AND DEFINING THE QBD PARADIGM
 TABLE 4 GROWTH IN THE BIOLOGICS MARKET, RISING DEMAND FOR COST-EFFECTIVE DRUG DEVELOPMENT, AND INCREASING ACCEPTANCE OF THE QBD APPROACH TO DRIVE MARKET GROWTH
 TABLE 5 PRICING PRESSURE FACED BY MAJOR PLAYERS AND SHORTAGE OF SKILLED PROFESSIONALS ARE RESTRAINING MARKET GROWTH
 TABLE 6 RISING DEMAND FOR SPECIALIZED ANALYTICAL TESTING SERVICES PROVIDE SIGNIFICANT GROWTH OPPORTUNITIES
 TABLE 7 SELECTED PUBLICATIONS AND GUIDELINES FOR THE CONTROL OF PHARMACEUTICAL IMPURITIES
 TABLE 8 INNOVATIVE FORMULATIONS AND MEDICAL DEVICES DEMANDING A UNIQUE ANALYTICAL TESTING APPROACH AND THE DEVELOPMENT OF APPROPRIATE DISSOLUTION METHODS ARE MAJOR MARKET CHALLENGES
 TABLE 9 MAJOR ACQUISITIONS IN HEALTHCARE ANALYTICAL TESTING SERVICES INDUSTRY (2013–2016)
 TABLE 10 ACTIVITIES OUTSOURCED IN PHARMACEUTICAL INDUSTRY (2015)
 TABLE 11 GLP REQUIREMENT FOR STUDIES
 TABLE 12 DEVELOPMENT OF GLP ACROSS COUNTRIES
 TABLE 13 OVERVIEW OF GUIDELINES OF LABORATORY SERVICES
 TABLE 14 SUMMARY OF GLP REGULATION (FDA)
 TABLE 15 REGULATORY AUTHORITIES AND LAUNCH OF GLP MONITORING PROGRAMS IN EUROPEAN COUNTRIES
 TABLE 16 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 70
 TABLE 17 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY COUNTRY, 2014–2021 (USD MILLION) 71
 TABLE 18 GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 73
 TABLE 19 GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 73
 TABLE 20 GLOBAL CELL-BASED ASSAY SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 74
 TABLE 21 GLOBAL VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 75
 TABLE 22 GLOBAL VIROLOGY TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 76
 TABLE 23 GLOBAL IN VITRO ASSAY SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 77
 TABLE 24 GLOBAL IN VIVO ASSAY SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 78
 TABLE 25 GLOBAL SPECIES-SPECIFIC VIRAL PCR ASSAY SERVICES MARKET SIZE,
 BY COUNTRY, 2014–2021 (USD MILLION) 79
 TABLE 26 METHOD VALIDATION CHARACTERISTICS FOR BIOPHARMACEUTICALS (AS PER ICH Q2A AND Q2B )
 TABLE 27 GLOBAL METHOD DEVELOPMENT OPTIMIZATION AND VALIDATION SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 28 GLOBAL IMMUNOGENICITY AND NEUTRALIZING ANTIBODY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 29 GLOBAL BIOMARKER TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 83
 TABLE 30 GLOBAL PHARMACOKINETIC TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
 TABLE 31 GLOBAL METABOLITE PROFILING AND MASS BALANCE STUDIES SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 32 GLOBAL PHYSICAL CHARACTERIZATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 87
 TABLE 33 GLOBAL PHYSICAL CHARACTERIZATION MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 87
 TABLE 34 GLOBAL LASER PARTICLE SIZE ANALYSIS SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 35 GLOBAL THERMAL ANALYSIS SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 89
 TABLE 36 GLOBAL IMAGE ANALYSIS SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 90
 TABLE 37 GLOBAL SURFACE AREA ANALYSIS SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 92
 TABLE 38 GLOBAL OTHER PHYSICAL CHARACTERIZATION SERVICES MARKET SIZE,
 BY COUNTRY, 2014–2021 (USD MILLION) 93
 TABLE 39 GLOBAL METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 94
 TABLE 40 GLOBAL METHOD VALIDATION SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 95
 TABLE 41 GLOBAL EXTRACTABLES & LEACHABLES METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 42 GLOBAL PROCESS IMPURITY METHOD DEVELOPMENT AND VALIDATION SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 43 GLOBAL CLEANING VALIDATION METHOD DEVELOPMENT SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 44 GLOBAL ANALYTICAL STANDARD CHARACTERIZATION SERVICES MARKET SIZE,
 BY COUNTRY, 2014–2021 (USD MILLION) 100
 TABLE 45 GLOBAL PEAK IDENTIFICATION SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 101
 TABLE 46 GLOBAL TECHNICAL CONSULTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 102
 TABLE 47 GLOBAL OTHER METHOD VALIDATION SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 48 GLOBAL RAW MATERIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 104
 TABLE 49 GLOBAL RAW MATERIAL TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 105
 TABLE 50 GLOBAL COMPLETE COMPENDIAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 51 GLOBAL HEAVY METAL TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 107
 TABLE 52 CHARACTERISTICS OF MAJOR CCI TESTING METHODS
 TABLE 53 GLOBAL CONTAINER TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 109
 TABLE 54 GLOBAL KARL FISCHER ANALYTICAL TESTING MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 110
 TABLE 55 GLOBAL WET CHEMISTRY ANALYSIS MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 111
 TABLE 56 GLOBAL OTHER RAW MATERIAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 57 GLOBAL BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 113
 TABLE 58 GLOBAL BATCH RELEASES TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 114
 TABLE 59 EVOLUTION OF FDA GUIDELINES FOR DISSOLUTION TESTING
 TABLE 60 GLOBAL DISSOLUTION TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 116
 TABLE 61 GLOBAL PHYSICAL TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 117
 TABLE 62 ICH PERMITTED DAILY EXPOSURE FOR ELEMENTAL IMPURITIES
 TABLE 63 GLOBAL ELEMENTAL IMPURITY TESTING SERVICES MARKET SIZE,
 BY COUNTRY, 2014–2021 (USD MILLION) 119
 TABLE 64 USP 32 DISINTEGRATION METHOD AND IMMERSION MEDIA INFORMATION
 TABLE 65 GLOBAL DISINTEGRATION TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 121
 TABLE 66 GLOBAL HARDNESS TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 122
 TABLE 67 GLOBAL FRIABILITY TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 123
 TABLE 68 GLOBAL OTHER BATCH RELEASE TESTING SERVICES MARKET SIZE,
 BY COUNTRY, 2014–2021 (USD MILLION) 124
 TABLE 69 CODES AND TITLES OF ICH STABILITY GUIDELINES
 TABLE 70 GUIDELINES DERIVED FROM INTERNATIONAL CONFERENCE ON HARMONISATION Q1A (R2)
 TABLE 71 GLOBAL STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 127
 TABLE 72 GLOBAL STABILITY TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 127
 TABLE 73 GLOBAL DRUG SUBSTANCE STABILITY TESTING SERVICES MARKET SIZE,
 BY COUNTRY, 2014–2021 (USD MILLION) 128
 TABLE 74 ICH GUIDELINE CODES FOR FORMULATION EVALUATION STABILITY TESTING SERVICES
 TABLE 75 GLOBAL FORMULATION EVALUATION STABILITY TESTING MARKET SIZE,
 BY COUNTRY, 2014–2021 (USD MILLION) 130
 TABLE 76 GLOBAL STABILITY INDICATING METHOD VALIDATION SERVICES MARKET SIZE,
 BY COUNTRY, 2014–2021 (USD MILLION) 132
 TABLE 77 ACCELERATED STABILITY STUDY CONDITION
 TABLE 78 GLOBAL ACCELERATED STABILITY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 79 PHARMACEUTICAL PRODUCT CLASS BASED ON PHOTOSENSITIVITY TESTING
 TABLE 80 GLOBAL PHOTOSTABILITY TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 135
 TABLE 81 GLOBAL COMPARATIVE STABILITY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 82 GLOBAL OTHER STABILITY TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 137
 TABLE 83 GLOBAL MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 138
 TABLE 84 GLOBAL MICROBIAL TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 139
 TABLE 85 STANDARD LIMIT FOR MICROBIAL LIMIT TESTING
 TABLE 86 GLOBAL MICROBIAL LIMIT TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 140
 TABLE 87 GLOBAL STERILITY TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 141
 TABLE 88 GLOBAL ENDOTOXIN TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 142
 TABLE 89 GLOBAL PRESERVATIVE EFFICACY TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 90 STANDARDIZED LIMITS FOR WATER TESTING
 TABLE 91 GLOBAL WATER TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 144
 TABLE 92 GLOBAL OTHER MICROBIAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 93 GLOBAL ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 146
 TABLE 94 GLOBAL ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 95 CLEANROOM CLASSIFICATION
 TABLE 96 LIMITS FOR PARTICULATE CONTAMINATION
 TABLE 97 GLOBAL AIR TESTING SERVICES MARKET SIZE, BY COUNTRY,
 2014–2021 (USD MILLION) 149
 TABLE 98 STANDARDS FOR WASTE WATER QUALITY
 TABLE 99 GLOBAL WASTEWATER/ETP TESTING SERVICES MARKET SIZE,
 BY COUNTRY, 2014–2021 (USD MILLION) 150
 TABLE 100 GLOBAL OTHER ENVIRONMENTAL MONITORING SERVICES MARKET SIZE,
 BY COUNTRY, 2014–2021 (USD MILLION) 151
 TABLE 101 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014–2021 (USD MILLION)
 TABLE 102 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE FOR RAW MATERIALS, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 103 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE FOR FINISHED PRODUCTS, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 104 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE FOR IN-PROCESS SAMPLES, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 105 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE FOR ENVIRONMENTAL SAMPLES, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 106 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY END USER, 2014–2021 (USD MILLION) 159
 TABLE 107 NUMBER OF DRUGS IN DEVELOPMENT ACROSS THE GLOBE, 2015
 TABLE 108 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY COUNTRY,
 2014-2021 (USD MILLION) 162
 TABLE 109 COVERAGE WITH EVIDENCE DEVELOPMENT (CED) SCHEMES IN GERMANY, FRANCE, AND U.K.
 TABLE 110 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE FOR MEDICAL DEVICE COMPANIES, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 111 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2014–2021 (USD MILLION)
 TABLE 112 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION)
 TABLE 113 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY COUNTRY, 2014–2021 (USD MILLION) 173
 TABLE 114 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 173
 TABLE 115 NORTH AMERICA: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 116 NORTH AMERICA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 117 NORTH AMERICA: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 175
 TABLE 118 NORTH AMERICA: RAW MATERIALS TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 175
 TABLE 119 NORTH AMERICA: BATCH RELEASE TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 176
 TABLE 120 NORTH AMERICA: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 176
 TABLE 121 NORTH AMERICA: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 177
 TABLE 122 NORTH AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE,
 BY TYPE, 2014-2021 (USD MILLION) 177
 TABLE 123 NORTH AMERICA: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 178
 TABLE 124 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY SAMPLE, 2014-2021 (USD MILLION) 178
 TABLE 125 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY END USER, 2014–2021 (USD MILLION) 178
 TABLE 126 MAJOR BIOLOGICS PATENT EXPIRIES IN THE U.S.
 TABLE 127 MAJOR STRATEGIC DEVELOPMENTS BY ANALYTICAL TESTING SERVICE PROVIDERS IN THE U.S.
 TABLE 128 U.S.: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 182
 TABLE 129 U.S.: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014-2021 (USD MILLION) 182
 TABLE 130 U.S.: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 183
 TABLE 131 U.S.: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 183
 TABLE 132 U.S.: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 184
 TABLE 133 U.S.: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 184
 TABLE 134 U.S.: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 185
 TABLE 135 U.S.: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 185
 TABLE 136 U.S.: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE,
 2014-2021 (USD MILLION) 186
 TABLE 137 U.S.: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 186
 TABLE 138 U.S.: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014-2021 (USD MILLION)
 TABLE 139 U.S.: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
 TABLE 140 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 141 CANADA: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014-2021 (USD MILLION) 188
 TABLE 142 CANADA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 189
 TABLE 143 CANADA: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 189
 TABLE 144 CANADA: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 190
 TABLE 145 CANADA: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 190
 TABLE 146 CANADA: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 191
 TABLE 147 CANADA: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 191
 TABLE 148 CANADA ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE,
 2014-2021 (USD MILLION) 192
 TABLE 149 CANADA: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 192
 TABLE 150 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY SAMPLE, 2014-2021 (USD MILLION) 192
 TABLE 151 CANADA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY END USER, 2014–2021 (USD MILLION) 193
 TABLE 152 EUROPE: PHARMACEUTICAL R&D EXPENDITURE AND PRODUCTION, BY COUNTRY (2012)
 TABLE 153 MAJOR STRATEGIC DEVELOPMENTS BY ANALYTICAL TESTING SERVICE PROVIDERS IN EUROPE
 TABLE 154 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY COUNTRY, 2014–2021 (USD MILLION) 196
 TABLE 155 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 196
 TABLE 156 EUROPE: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014-2021 (USD MILLION) 197
 TABLE 157 EUROPE: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 197
 TABLE 158 EUROPE: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 198
 TABLE 159 EUROPE: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 198
 TABLE 160 EUROPE: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 199
 TABLE 161 EUROPE: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 199
 TABLE 162 EUROPE: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 200
 TABLE 163 EUROPE: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE,
 BY TYPE, 2014-2021 (USD MILLION) 200
 TABLE 164 EUROPE: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 201
 TABLE 165 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY SAMPLE, 2014-2021 (USD MILLION) 201
 TABLE 166 EUROPE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY END USER, 2014–2021 (USD MILLION) 202
 TABLE 167 PHARMACEUTICAL PRODUCTION IN GERMANY (2009-2013)
 TABLE 168 BIOTECHNOLOGY INDUSTRY IN GERMANY (2009-2014)
 TABLE 169 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 170 GERMANY: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014-2021 (USD MILLION) 204
 TABLE 171 GERMANY: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 204
 TABLE 172 GERMANY: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 205
 TABLE 173 GERMANY: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 205
 TABLE 174 GERMANY: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 206
 TABLE 175 GERMANY: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 206
 TABLE 176 GERMANY: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 207
 TABLE 177 GERMANY: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE,
 BY TYPE, 2014-2021 (USD MILLION) 207
 TABLE 178 GERMANY: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 208
 TABLE 179 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY SAMPLE, 2014-2021 (USD MILLION) 208
 TABLE 180 GERMANY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY END USER, 2014–2021 (USD MILLION) 209
 TABLE 181 U.K.: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 210
 TABLE 182 U.K.: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014-2021 (USD MILLION) 210
 TABLE 183 U.K.: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 184 U.K.: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 211
 TABLE 185 U.K.: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 212
 TABLE 186 U.K.: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 212
 TABLE 187 U.K.: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 213
 TABLE 188 U.K.: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 213
 TABLE 189 U.K.: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 214
 TABLE 190 U.K.: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 214
 TABLE 191 U.K.: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014–2021 (USD MILLION)
 TABLE 192 U.K.: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
 TABLE 193 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 194 FRANCE: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 216
 TABLE 195 FRANCE: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 217
 TABLE 196 FRANCE: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 217
 TABLE 197 FRANCE: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 218
 TABLE 198 FRANCE: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 218
 TABLE 199 FRANCE: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 219
 TABLE 200 FRANCE: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 219
 TABLE 201 FRANCE: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 202 FRANCE: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 220
 TABLE 203 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY SAMPLE, 2014–2021 (USD MILLION) 220
 TABLE 204 FRANCE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY END USER, 2014–2021 (USD MILLION) 221
 TABLE 205 CLINICAL TRIALS PER DRUG TYPOLOGY (2013 VS. 2014)
 TABLE 206 CLINICAL TRIALS PER OUTCOME (2013 VS. 2014)
 TABLE 207 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 208 ITALY: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 223
 TABLE 209 ITALY: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 210 ITALY: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 224
 TABLE 211 ITALY: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 224
 TABLE 212 ITALY: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 225
 TABLE 213 ITALY: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 225
 TABLE 214 ITALY: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 226
 TABLE 215 ITALY: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 226
 TABLE 216 ITALY: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 227
 TABLE 217 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014-2021 (USD MILLION)
 TABLE 218 ITALY: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
 TABLE 219 SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 220 SPAIN: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 229
 TABLE 221 SPAIN: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 222 SPAIN: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 230
 TABLE 223 SPAIN: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 231
 TABLE 224 SPAIN: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 231
 TABLE 225 SPAIN: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 232
 TABLE 226 SPAIN: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 232
 TABLE 227 SPAIN: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 233
 TABLE 228 SPAIN: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 233
 TABLE 229 SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY SAMPLE, 2014-2021, (USD MILLION) 233
 TABLE 230 SPAIN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY END USER, 2014–2021 (USD MILLION) 234
 TABLE 231 PHARMACEUTICAL PRODUCTION AND R&D EXPENDITURE IN DENMARK
 (2012 VS 2013) 235
 TABLE 232 ROE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 235
 TABLE 233 ROE: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 236
 TABLE 234 ROE: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 236
 TABLE 235 ROE: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 237
 TABLE 236 ROE: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 237
 TABLE 237 ROE: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 238
 TABLE 238 ROE: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 238
 TABLE 239 ROE: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 239
 TABLE 240 ROE: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 239
 TABLE 241 ROE: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 239
 TABLE 242 ROE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014-2021 (USD MILLION)
 TABLE 243 ROE: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
 TABLE 244 ASIA-PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 243
 TABLE 245 ASIA-PACIFIC: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 243
 TABLE 246 ASIA-PACIFIC: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 244
 TABLE 247 ASIA-PACIFIC: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 244
 TABLE 248 ASIA-PACIFIC: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 245
 TABLE 249 ASIA-PACIFIC: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 245
 TABLE 250 ASIA-PACIFIC: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 246
 TABLE 251 ASIA-PACIFIC: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 246
 TABLE 252 ASIA-PACIFIC: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 247
 TABLE 253 ASIA-PACIFIC: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 254 ASIA-PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY SAMPLE, 2014–2021 (USD MILLION) 247
 TABLE 255 ASIA-PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY END USER, 2014–2021 (USD MILLION) 248
 TABLE 256 COST OF CLINICAL TRIALS: U.S. AND CHINA (2012)
 TABLE 257 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 258 CHINA: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 250
 TABLE 259 CHINA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 260 CHINA: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 251
 TABLE 261 CHINA: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 251
 TABLE 262 CHINA: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 252
 TABLE 263 CHINA: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 252
 TABLE 264 CHINA: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 253
 TABLE 265 CHINA: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 253
 TABLE 266 CHINA: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 254
 TABLE 267 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY SAMPLE, 2014–2021 (USD MILLION) 254
 TABLE 268 CHINA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY END USER, 2014–2021 (USD MILLION) 254
 TABLE 269 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 256
 TABLE 270 JAPAN: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 256
 TABLE 271 JAPAN: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 272 JAPAN: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 257
 TABLE 273 JAPAN: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 258
 TABLE 274 JAPAN: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 258
 TABLE 275 JAPAN: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 259
 TABLE 276 JAPAN: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 259
 TABLE 277 JAPAN: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 260
 TABLE 278 JAPAN: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 260
 TABLE 279 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014–2021 (USD MILLION)
 TABLE 280 JAPAN: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
 TABLE 281 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 282 INDIA: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 262
 TABLE 283 INDIA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 284 INDIA: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 263
 TABLE 285 INDIA: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 264
 TABLE 286 INDIA: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 264
 TABLE 287 INDIA: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 265
 TABLE 288 INDIA: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 265
 TABLE 289 INDIA: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 266
 TABLE 290 INDIA: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 266
 TABLE 291 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014–2021 (USD MILLION)
 TABLE 292 INDIA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
 TABLE 293 REST OF APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 268
 TABLE 294 REST OF APAC: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 268
 TABLE 295 REST OF APAC: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 296 REST OF APAC: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 269
 TABLE 297 REST OF APAC: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 298 REST OF APAC: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 299 REST OF APAC: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 271
 TABLE 300 REST OF APAC: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 271
 TABLE 301 REST OF APAC: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 272
 TABLE 302 REST OF APAC: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 303 REST OF APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY SAMPLE, 2014–2021 (USD MILLION) 272
 TABLE 304 REST OF APAC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY END USER, 2014–2021 (USD MILLION) 273
 TABLE 305 ROW: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 274
 TABLE 306 ROW: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 275
 TABLE 307 ROW: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 275
 TABLE 308 ROW: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 276
 TABLE 309 ROW: RAW MATERIALS TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 276
 TABLE 310 ROW: BATCH RELEASE TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 277
 TABLE 311 ROW: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 277
 TABLE 312 ROW: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 278
 TABLE 313 ROW: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 278
 TABLE 314 ROW: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 278
 TABLE 315 ROW: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY SAMPLE, 2014–2021 (USD MILLION) 279
 TABLE 316 ROW: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY END USER, 2014–2021 (USD MILLION) 279
 TABLE 317 GROSS EXPENDITURE ON R&D IN MAJOR LATIN AMERICAN COUNTRIES
 TABLE 318 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 281
 TABLE 319 LATIN AMERICA: BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 320 LATIN AMERICA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 321 LATIN AMERICA: METHOD VALIDATION SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 283
 TABLE 322 LATIN AMERICA: RAW MATERIALS TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 283
 TABLE 323 LATIN AMERICA: BATCH RELEASE TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 284
 TABLE 324 LATIN AMERICA: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 284
 TABLE 325 LATIN AMERICA: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 285
 TABLE 326 LATIN AMERICA: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE,
 2014–2021 (USD MILLION) 285
 TABLE 327 LATIN AMERICA: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 286
 TABLE 328 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY SAMPLE, 2014–2021 (USD MILLION) 286
 TABLE 329 LATIN AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE,
 BY END USER, 2014–2021 (USD MILLION) 287
 TABLE 330 MIDDLE EAST AND AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 331 MIDDLE EAST AND AFRICA: BIOANALYTICAL TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 288
 TABLE 332 MIDDLE EAST AND AFRICA: PHYSICAL CHARACTERIZATION TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 333 MIDDLE EAST AND AFRICA: METHOD VALIDATION SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 289
 TABLE 334 MIDDLE EAST AND AFRICA: RAW MATERIALS TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 290
 TABLE 335 MIDDLE EAST AND AFRICA: BATCH RELEASE TESTING SERVICES MARKET SIZE,
 BY TYPE, 2014–2021 (USD MILLION) 290
 TABLE 336 MIDDLE EAST AND AFRICA: STABILITY TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 337 MIDDLE EAST AND AFRICA: MICROBIAL TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 338 MIDDLE EAST AND AFRICA: VIROLOGY TESTING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 339 MIDDLE EAST AND AFRICA: ENVIRONMENTAL MONITORING SERVICES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION)
 TABLE 340 MIDDLE EAST AND AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY SAMPLE, 2014–2021 (USD MILLION)
 TABLE 341 MIDDLE EAST AND AFRICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION)
 TABLE 342 GROWTH STRATEGY MATRIX
 TABLE 343 ACQUISITIONS, 2013–2016
 TABLE 344 EXPANSIONS, 2013–2016
 TABLE 345 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, 2013–2016
 TABLE 346 SERVICE LAUNCHES, 2013–2016


List Of Figures

FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 3 BOTTOM-UP APPROACH
FIGURE 4 TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION METHODOLOGY
FIGURE 6 BIOANALYTICAL TESTING SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 7 ELEMENTAL IMPURITY TESTING SEGMENT EXPECTED TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 8 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET, BY SAMPLE TYPE, 2016 VS. 2021 (USD MILLION)
FIGURE 9 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 10 GEOGRAPHIC SNAPSHOT: GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
FIGURE 11 GROWING DEMAND FOR ANALYTICAL SERVICES FOR BIOLOGICS AND LARGE MOLECULE DRUGS TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 12 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES COMMANDED THE LARGEST SHARE OF THE APAC HEALTHCARE ANALYTICAL TESTING SERVICES MARKET IN 2015
FIGURE 13 U.S. DOMINATED THE GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET IN 2015
FIGURE 14 NORTH AMERICA TO DOMINATE THE GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET DURING THE FORECAST PERIOD
FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 16 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SEGMENTATION,
BY TYPE 49
FIGURE 17 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SEGMENTATION,
BY END USER 50
FIGURE 18 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SEGMENTATION,
BY SAMPLE 50
FIGURE 19 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 20 TRADITIONAL AND AQBD APPROACHES FOR ANALYTICAL METHOD DEVELOPMENT
FIGURE 21 GROWING CONSOLIDATION IN THE ANALYTICAL TESTING SERVICES INDUSTRY AND OUTSOURCING OF ANALYTICAL TESTING SERVICES ARE LEADING INDUSTRY TRENDS
FIGURE 22 TACTICAL OUTSOURCING VS STRATEGIC OUTSOURCING (2014)
FIGURE 23 CELL-BASED ASSAYS WILL CONTINUE TO DOMINATE THE BIOANALYTICAL TESTING SERVICES MARKET DURING FORECAST PERIOD
FIGURE 24 LASER PARTICLE SIZE ANALYSIS WILL CONITINUE TO DOMINATE THE PHYSICAL CHARACTERIZATION SERVICES MARKET DURING THE FORECAST PERIOD
FIGURE 25 EXTRACTABLES AND LEACHABLES METHOD DEVELOPMENT AND VALIDATION PROCESS
FIGURE 26 STABILITY STUDIES AT DIFFERENT PHASES OF DRUG DEVELOPMENT
FIGURE 27 STABILITY INDICATING METHOD VALIDATION SERVICES IN THE PHARMACEUTICAL INDUSTRY
FIGURE 28 PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES TO DOMINATE THE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET
FIGURE 29 R&D SPENDING OF PHRMA MEMBER COMPANIES, 1980-2014
FIGURE 30 HEALTHCARE ANALYTICAL TESTING SERVICES MARKET GROWTH RATE,
BY COUNTRY/REGION (2016–2021) 169
FIGURE 31 NORTH AMERICA: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SNAPSHOT
FIGURE 32 PHARMACEUTICAL R&D EXPENDITURE IN THE U.S. (1990–2013)
FIGURE 33 NEW MOLECULAR ENTITY AND NEW BIOLOGIC LICENSE APPLICATION APPROVALS
FIGURE 34 PHARMACEUTICAL R&D EXPENDITURE IN EUROPE (2010 VS. 2013)
FIGURE 35 NUMBER OF NEW CHEMICAL OR BIOLOGICAL ENTITIES IN EUROPE (2004–2013)
FIGURE 36 ASIA-PACIFIC: HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SNAPSHOT
FIGURE 37 ACQUISITIONS—KEY GROWTH STRATEGY PURSUED BY PLAYERS IN THE HEALTHCARE ANALYTICAL TESTING SERVICES MARKET FROM 2013 TO 2016
FIGURE 38 GLOBAL HEALTHCARE ANALYTICAL TESTING SERVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2015
FIGURE 39 BATTLE FOR MARKET SHARE: ACQUISITIONS IS THE KEY GROWTH STRATEGY
FIGURE 40 GEOGRAPHICAL REVENUE MIX OF THE TOP 4 PLAYERS
FIGURE 41 COMPANY SNAPSHOT: EUROFINS SCIENTIFIC SE
FIGURE 42 COMPANY SNAPSHOT: SGS
FIGURE 43 COMPANY SNAPSHOT: CHARLES RIVER LABORATORIES INTERNATIONAL INC.
FIGURE 44 COMPANY SNAPSHOT: WUXI PHARMATECH (CAYMAN) INC.
FIGURE 45 COMPANY SNAPSHOT: EXOVA GROUP PLC
FIGURE 46 COMPANY SNAPSHOT: INTERTEK GROUP PLC.
FIGURE 47 COMPANY SNAPSHOT: BIORELIANCE CORPORATION
FIGURE 48 COMPANY SNAPSHOT: SOURCE BIOSCIENCE


Helsinn Healthcare S.A Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Helsinn Healthcare S.A Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200View Report

HealthCare Ventures LLC Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

HealthCare Ventures LLC Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT profile,

USD 200View Report

Healthcare Trust of America, Inc. - .. Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Healthcare Trust of America, Inc. - .. Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current

USD 200View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 4650
  • Hard copy    $ 5650
  • CD    $ 7150
$ 4650

Reports Details

Published Date : May 2016
No. of Pages :346
Country :Global
Category :Healthcare
Publisher :MarketsandMarkets
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment